LPS-binding protein (LBP) can facilitate the transfer of cell wall components of both Gram-negative bacteria (LPS) and Gram-positive bacteria (lipoteichoic acid) to inflammatory cells. Although LBP is predominantly produced in the liver, recent studies have indicated that this protein is also synthesized locally in the lung by epithelial cells. To determine the role of LBP in the immune response to pneumonia, LBP gene-deficient (ÿ/ÿ) and normal wild-type (WT) mice were intra-nasally infected with either Streptococcus pneumoniae or Klebsiella pneumoniae, common Gram-positive and Gram-negative pathogens, respectively. Pneumococcal pneumonia was associated with a 7-fold rise in LBP concentrations in bronchoalveolar lavage fluid of WT mice; LBPÿ/ÿ mice infected with S. pneumoniae showed a similar survival and a similar bacterial burden in their lungs 48 h postinfection. In Klebsiella pneumonia, however, LBPÿ/ÿ mice demonstrated a diminished survival together with an enhanced bacterial outgrowth in their lungs. These data suggest that LBP is important for a protective immune response in Klebsiella pneumonia, but does not contribute to an effective host response in pneumococcal pneumonia.
Introduction

LPS-binding protein (LBP)
is an acute-phase protein that binds and disaggregates LPS from Gram-negative bacteria, and facilitates the presentation of LPS monomers to the pattern recognition receptor CD14 on immunocompetent cells (1, 2) . After binding of the LBP-LPS complex to CD14, intracellular activation proceeds via Toll-like receptor 4 (TLR4) by a mechanism that requires an additional extracellular protein, MD-2 (3) (4) (5) . In the absence of LBP, animals demonstrate a markedly diminished responsiveness to LPS. Indeed, rabbits or mice treated with anti-LBP antibodies and LBP gene-deficient (LBPÿ/ÿ) mice were protected against LPS-induced lethality in association with inhibition of systemic tumor necrosis factor (TNF) release (6) (7) (8) (9) . Evidence exists that the absence of a strong and rapid inflammatory response to LPS makes LBPÿ/ÿ mice more susceptible to at least some intra-peritoneal and intravenous Gram-negative infections. LBPÿ/ÿ mice were unable to clear low doses of Salmonella typhimurium (9) (10) (11) (12) , resulting in increased lethality when compared with normal LBP+/+ wild-type (WT) mice. Furthermore, mice pre-treated with a neutralizing mAb to LBP died from overwhelming infection within 24 h after intravenous injection of a low dose of a virulent Klebsiella pneumoniae strain (13) . However, anti-LBP treatment did not influence lethality induced by a higher intravenous inoculum of the same Klebsiella strain and did not affect outcome following injection with a low or high dose of an avirulent Escherichia coli strain (13) .
Gram-positive bacteria do not contain LPS in their bacterial cell wall. Important pro-inflammatory cell wall components of Gram-positive bacteria are lipoteichoic acid (LTA) and peptidoglycan (PGN) (14, 15) . Like LPS, these Gram-positive bacterial antigens are recognized by CD14 (16) (17) (18) (19) (20) (21) , and their presentation to CD14 can be enhanced by LBP (22) (23) (24) (25) . Knowledge of the role of LBP in immune stimulation by Grampositive bacteria in vivo is limited. One study has reported an unaltered influx of neutrophils into the peritoneal cavity after intra-peritoneal administration of Staphylococcus aureus (12) . In contrast, another recent study reported a diminished influx of leukocytes into the cerebrospinal fluid (CSF) in pneumococcal meningitis in LBP-deficient mice (26) .
Pneumonia is a common and serious illness and is the leading cause of death due to infectious diseases in the United States (27) . Common respiratory pathogens include the Gramnegative bacterium K. pneumoniae and the Gram-positive bacterium Streptococcus pneumoniae. Whereas K. pneumoniae is a causative organism in both community-acquired and nosocomial pneumonia, S. pneumoniae is the most commonly isolated pathogen in patients with community-acquired pneumonia (28, 29) . Little is known about the role of LBP in anti-bacterial defense in the pulmonary compartment in vivo. Several lines of evidence indicate that LBP may be involved in the induction of an innate immune response in the lung during pneumonia. LBP is a product of alveolar epithelial cells of which the release is regulated by pro-inflammatory cytokines (30) , and LBP can enhance the responsiveness of alveolar macrophages to LPS (31) . In addition, LBP concentrations were elevated in bronchoalveolar lavage fluid (BALF) of patients with acute lung injury or allergic lung inflammation (32, 33) , suggesting that LBP behaves as an acute-phase protein in the lung. Therefore, in the present study we sought to determine the role of LBP in the host response to Gramnegative and Gram-positive pneumonia. For this purpose, LBPÿ/ÿ and LBP+/+ WT mice were intra-nasally inoculated with either S. pneumoniae or K. pneumoniae, and the course of the infections was followed by monitoring survival, bacterial outgrowth and host inflammatory responses.
Methods
Animals
LBPÿ/ÿ mice, back-crossed 11 times to a C57Bl/6 background, were generated as described previously (34) . Normal LBP+/+ C57Bl/6 WT mice were purchased from Harlan Sprague Dawley Inc. (Horst, The Netherlands). Male mice, aged 8-9 weeks, were used. All experiments were approved by the Animal Care and Use Committee of the University of Amsterdam (Amsterdam, The Netherlands).
Induction of pneumonia
Pneumonia was induced as described before (35) (36) (37) . Streptococcus pneumoniae serotype 3 [American Type Tissue Collection, Rockville, MD (ATCC) 6303] was used for Grampositive infection. Pneumococci were cultured for 16 h at 37°C in 5% CO 2 in Todd-Hewitt broth (Difco, Detroit, MI, USA). This suspension was diluted 1:100 in fresh medium and grown for 5 h to mid-logarithmic phase. Klebsiella pneumoniae serotype 2 (ATCC 43816) was used for Gram-negative infection. Klebsiella bacteria were cultured for 16 h at 37°C in 5% CO 2 in tryptic soy broth (Difco). This suspension was diluted 1:100 in fresh medium and grown for 3 h to mid-logarithmic phase. Streptococcus pneumoniae and K. pneumoniae were harvested by centrifugation at 1500 g for 15 min and washed twice in sterile 0.9% saline. Bacteria were re-suspended in saline at different concentrations, as determined by plating 10-fold dilutions of the suspensions on blood agar plates. After preparation of the bacterial inocula, mice were lightly anesthetized by inhalation of isoflurane (Upjohn, Ede, The Netherlands) and 50 ll of the bacterial suspension [containing 10 5 colony-forming units (CFU) S. pneumoniae or 10 3 CFU K. pneumoniae] was inoculated intra-nasally. Control mice received 50 ll of saline.
LBP measurement
LBP concentrations in plasma and BALF of WT mice were measured. EDTA-anticoagulated blood was spun at 1000 g at 4°C for 10 min, after which plasma was stored at ÿ20°C until further use. For bronchoalveolar lavage (BAL), the trachea was exposed through a midline incision and cannulated with a sterile 22-gauge Abbocath-T catheter (Abbott, Sligo, Ireland). BAL was performed by instilling two 0.5-ml aliquots of sterile isotonic saline. A total of 0.9-1.0 ml of lavage fluid was retrieved per mouse. BALF was spun at 250 g at 4°C for 10 min; the supernatant was frozen at ÿ20°C until further use. LBP was measured by ELISA according to the manufacturer's instructions (HyCult Biotechnology B.V., Uden, The Netherlands).
Determination of bacterial outgrowth
At 6, 24 or 48 h after infection, mice were anesthetized by administering 7.0 ml kg ÿ1 of a mixture of 0.079 mg ml ÿ1 fentanyl citrate, 2.5 mg ml ÿ1 fluanisone and 1.25 mg ml ÿ1 midazolam in H 2 O intra-peritoneally, and sacrificed by bleeding out the vena cava inferior. Blood was collected in EDTA-containing microtubes (Becton Dickinson, Meylan, France). Both lungs were harvested, and the right lung was homogenized at 4°C in four volumes of sterile saline using a tissue homogenizer (Biospec Products, Bartlesville, OK, USA). Serial 10-fold dilutions were made in sterile saline and 10-ll volumes were plated on blood agar plates. In addition, 20-ll volumes of blood were plated. Plates were incubated at 37°C in 5% CO 2 , and CFU were counted after 16 h.
Cell counts in the lungs
In the same experiment, pulmonary cell suspensions were obtained from the left lung using an automated disaggregation device (Medimachine-system, Dako, Glostrup, Denmark) as described (38) . After erythrocytes had been lysed with icecold isotonic NH 4 Cl solution (155 mM NH 4 Cl, 10 mM KHCO 3 , 100 mM EDTA, pH 7.4), pulmonary cells were suspended in RPMI medium (BioWhittaker, Verviers, Belgium). Total cell numbers in each sample were counted using a hemacytometer (Beckmann Coulter, Fullerton, CA, USA). Granulocyte counts in the cell suspensions were assessed using cytospin preparations stained with a modified Giemsa stain (Diff-Quick, Baxter, McGraw Park, IL, USA).
Cytokine and chemokine measurements
For cytokine measurements, lung homogenates were diluted 1:2 in lysis buffer (150 mM NaCl, 15 mM Tris, 1 mM MgCl 2 ÁH 2 O, 1 mM CaCl 2 , 1% Triton X-100, 100 lg ml ÿ1 pepstatin A, leupeptin and aprotinin, pH 7.4) and incubated at 4°C for 30 min. Homogenates were centrifuged at 1500 g for 15 min after which the supernatants were stored at ÿ20°C until further use. Cytokine and chemokine levels in lung homogenates were measured by ELISA according to the manufacturer's instructions: TNFa, IL-6, macrophage inflammatory protein-2 (MIP-2) and keratinocyte (KC) assay kits were all obtained from R&D (Minneapolis, MN, USA).
Histologic examination
Lungs for histologic examination were harvested at 24 h (K. pneumoniae pneumonia) and 48 h (S. pneumoniae pneumonia) after inoculation, fixed in 10% formalin and embedded in paraffin. Four-micrometer sections were stained with hematoxylin and eosin, and analyzed by a pathologist who was blinded to groups.
Statistical analysis
All data are expressed as mean 6 SEM. Differences between groups were analyzed by Mann-Whitney U test. Survival studies were analyzed using Kaplan-Meier curves. P < 0.05 was considered to represent a statistically significant difference.
Results
LBP concentrations
To obtain insight into local LBP concentrations in the bronchoalveolar compartment, we measured LBP protein levels in BALF of uninfected mice and mice with respiratory tract infection with either S. pneumoniae or K. pneumoniae (Fig. 1) . LBP was detected at levels of 15-53 ng ml ÿ1 in BALF of uninfected mice. Pneumococcal pneumonia was associated with a significant 7-fold increase in BALF LBP levels relative to controls, as measured 48 h after infection (P < 0.05 versus controls). Klebsiella pneumonia resulted in a more modest 2-fold rise in BALF LBP levels (non-significant versus controls). As expected, LBP was not detectable in BALF or plasma obtained from LBPÿ/ÿ mice.
Survival
In Gram-positive pneumonia induced by S. pneumoniae, survival did not differ between LBPÿ/ÿ and WT mice ( Fig. 2A) .
In contrast, in Gram-negative pneumonia, survival was significantly impaired in LBPÿ/ÿ mice compared with WT mice (P < 0.05). All LBPÿ/ÿ mice died within 3 days while 37.5% of the WT mice were permanent survivors (Fig. 2B) . These data suggest that LBP is important for protection against mortality induced by K. pneumoniae, while LBP does not seem to be of importance in pneumococcal pneumonia.
Bacterial outgrowth
To obtain more insight into the role of LBP in early host defense against Gram-positive and Gram-negative pneumonia, bacterial outgrowth in the lungs of LBPÿ/ÿ and WT mice was compared. After infection with S. pneumoniae, bacteria were counted at 24 and 48 h. At 24 h post-infection, LBPÿ/ÿ lungs contained slightly but significantly less CFU compared with WT lungs (P < 0.05). This difference, however, had disappeared at 48 h (Fig. 3A) . The percentage of positive blood cultures in LBPÿ/ÿ and WT mice was similar, i.e. 57 and 63% at 24 h, and 57 and 75% at 48 h, respectively.
In Gram-negative pneumonia, the bacterial load in the lungs was assessed 6 and 24 h after inoculation with K. pneumoniae. Time points earlier than those in the pneumococcal model were chosen considering the early mortality of LBPÿ/ÿ mice during Klebsiella pneumonia. Although bacterial counts were similar in both mouse strains at the 6-h time point, LBPÿ/ÿ mouse lungs contained 3 logs more bacteria at the 24-h time point compared with WT mice (P < 0.05; Fig. 3B ). In Klebsiella pneumonia, at 6 h, all blood cultures were negative, whereas at 24 h, blood cultures were positive in the majority of mice (88% of LBPÿ/ÿ mice and 63% of WT mice). Of note, blood derived from LBPÿ/ÿ mice contained~2 logs more bacteria than blood from WT mice (data not shown). This finding is in concordance with the bacterial outgrowth in the lungs at the same time point.
Granulocyte influx in the lungs
The rapid influx of granulocytes to the site of infection is an important characteristic of the innate immune response during pneumonia (39) . We therefore determined granulocyte numbers in whole-lung cell suspensions at 6, 24 and 48 h after induction of respiratory tract infection. In S. pneumoniae pneumonia, LBPÿ/ÿ mouse lungs contained similar numbers of granulocytes compared with WT mouse lungs at both 24 and 48 h post-inoculation (Table 1) . Likewise, in pneumonia induced by K. pneumoniae, no difference in granulocyte counts in lungs of LBPÿ/ÿ and WT mice was seen after either 6 or 24 h (Table 1) .
Cytokine and chemokine response to pneumonia
In pulmonary infections, local cytokine and chemokine production is an important factor in the host immune response (39, 40) . We determined the influence of LBP on pulmonary cytokine concentrations during pneumococcal and Klebsiella pneumonia. Cytokine (TNFa, IL-6) and chemokine (MIP-2, KC) levels in lung homogenates measured 24 and 48 h after induction of pneumococcal pneumonia did not differ between LBPÿ/ÿ and WT mice (data not shown). In K. pneumoniae infection, TNFa, IL-6, MIP-2 and KC concentrations were similar in LBPÿ/ÿ and WT mice 6 h after infection (data not shown). In contrast, after 24 h, all cytokine and chemokine levels measured were significantly elevated in LBPÿ/ÿ mice compared with WT mice (P < 0.05; Table 2 ).
Histopathology
At 48 h after induction of S. pneumoniae infection, lungs of both WT (Fig. 4A) and LBPÿ/ÿ (Fig. 4B) mice displayed dense granulocytic infiltrates around vessels, edema, endothelialitis and pleuritis. The distribution and intensity of the inflammatory infiltrates were comparable in WT and LBPÿ/ÿ mice.
Infection with K. pneumoniae was characterized by a predominantly interstitial inflammation in the lungs as shown in Fig. 4 (C and D) at 24 h after inoculation. No significant difference could be detected between WT (Fig. 4C) and LBPÿ/ÿ (Fig. 4D) mice. Granulocyte counts in lungs of LBPÿ/ÿ and WT mice at 24 and 48 h after intra-nasal inoculation with 10 5 CFU S. pneumoniae and at 6 and 24 h after intra-nasal inoculation with 10 3 CFU K. pneumoniae. Data are mean 6 SEM of 7-8 mice. determine the relevance of LBP in inducing an innate host response to pulmonary infection, we induced pneumonia caused by two common respiratory pathogens (Grampositive, S. pneumoniae, and Gram-negative, K. pneumoniae) in LBPÿ/ÿ and WT mice. The outcome of S. pneumoniae pneumonia was not influenced by the absence of LBP, as reflected by similar survival curves and similar bacterial outgrowth after 48 h in LBPÿ/ÿ and WT mice. In contrast, in K. pneumoniae pneumonia, the protective role of LBP was evident as shown by an increased mortality rate and an increased number of bacteria in lungs of LBPÿ/ÿ mice compared with WT mice. Evidence indicates that LBP can be produced not only in the liver, but also in a variety of tissues including the lungs (30, 31, (41) (42) (43) . Elevated levels of LBP in BALF of patients with acute respiratory distress syndrome and in BALF of asthma patients after allergen challenge (31) (32) (33) suggest that local production of LBP may contribute to host defense against bacterial challenges in the lung. We here demonstrate that mice have detectable LBP concentrations in their BALF, which increase upon bacterial respiratory tract infection, in particular during pneumococcal pneumonia.
During bacterial growth and death, large amounts of bacterial cell wall components such as LPS, LTA and PGN are released. It is known that LBP can bind to these components. Moreover, in vitro studies have shown that LBP can also opsonize intact Gram-negative and -positive bacteria including S. pneumoniae (26, 44) .
Several in vitro studies have attributed an important role to LBP in activating cells upon stimulation with components of Gram-positive bacteria. It was shown that TNFa production by monocytes in response to pneumococcal and staphylococcal LTA (25) and group B streptococcal (24) and pneumococcal cell walls (26) was dose dependently enhanced by the presence of LBP. LBP was also shown to play a stimulating role in the recognition and phagocytosis of the Gram-positive bacterium Bacillus subtilis by CD14-expressing CHO and U937 cells (23) . Others, however, were unable to show a modulating effect of LBP on TNFa production by PBMC in response to B. subtilis and Staphylococcus aureus LTA (21) . Data on the effect of LBP in cell activation induced by PGN, another important immunostimulatory component of Grampositive bacteria, remain controversial. Binding of PGN to the CD14 receptor was enhanced by the presence of LBP in in vitro experiments (22) . In two earlier reports, however, LBP failed to augment PGN-induced cell activation (45, 46) . Data on the role of LBP in Gram-positive infections in vivo are limited. Weber et al. (26) showed a decreased influx of leukocytes in the CSF of LBPÿ/ÿ mice in a model of meningitis induced by live pneumococci and pneumococcal cell walls. However, the absence of LBP did not influence host defense as measured by similar numbers of CFU in the CSF of LBPÿ/ÿ and WT mice. In line with these findings, we show that the absence of LBP in a murine model of pneumococcal pneumonia does not affect innate host defense mechanisms. LBP-deficient mice were able to mount an inflammatory response comparable to WT mice as shown by similar survival curves, bacterial numbers and neutrophil influx in the pulmonary compartment as well as cytokine production and histopathology scores. At 24 h post-infection, LBPÿ/ÿ mice even displayed slightly less pneumococci in their lungs than WT mice. A recent study has implicated TLR4 in the early recognition of S. pneumoniae in the respiratory tract via a specific interaction with pneumolysin, a cytolytic toxin expressed by the pneumococcus (47) . The current data suggest that LBP does not play a role herein.
Since its discovery in 1986 (48), LBP has been shown to be important in the induction of an inflammatory response against LPS (1, 6-9, 44, 49) and Gram-negative bacteria (9-11, 13, 50) . In our experiments, LBP clearly played a protective role in K. pneumoniae pneumonia. While our studies were in progress, Fan et al. (51) reported similar data on survival and bacterial outgrowth during Klebsiella pneumonia in LBPÿ/ÿ mice. Of note, whereas Fan et al. showed a reduced influx of granulocytes into the pulmonary compartment of LBPÿ/ÿ mice, we found similar granulocyte numbers in LBPÿ/ÿ and WT mice. In addition, we detected a profound increase in cytokine and chemokine concentrations in lung homogenates of LBPÿ/ÿ mice compared with WT mice, while Fan et al. found either similar or lower cytokine and chemokine levels in LBPÿ/ÿ versus WT mice. In our opinion, the impressive difference in pulmonary bacterial load (3 logs) in LBPÿ/ÿ versus WT mice, providing a more potent pro-inflammatory stimulus, is responsible for our findings. Furthermore, a reduced capacity of phagocytes to phagocytose and kill bacteria in the absence of LBP may also play a role, since in vitro studies showed enhanced phagocytosis and killing of bacteria by alveolar macrophages in the presence of LBP (52, 53) .
Although, in recent years, much has been learnt from in vitro studies involving LBP, knowledge about the function of LBP during infections in vivo is limited. In light of the clinical relevance of pulmonary infections worldwide, we considered it important to evaluate the role of LBP during Gram-positive and Gram-negative pneumonia. We conclude that LBP plays an essential role in innate immunity during pneumonia caused by K. pneumoniae but does not contribute to host defense in pneumococcal pneumonia. Further research is warranted to establish the role of LBP in the pulmonary immune response to other respiratory pathogens. 
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